Objective The functional ADRA2B I/D polymorphism is associated with various cardiovascular and metabolic phenotypes in Caucasians. The purpose of our study was to investigate whether the ADRA2B I/D polymorphism is associated with such phenotypes in a Chinese population.
Introduction
Catecholamines play an important role in the regulation of blood pressure and metabolism in humans. Three aadrenergic receptor subtypes have been identified. Stimulation of the a2A-adrenoceptor reduces sympathetic outflow from the central nervous system and leads to a decrease in blood pressure [1, 2] . Stimulation of the a2B-adrenoceptor opposes the centrally mediated effects of the a2A-adrenoceptor. The a2C subtype seems to have no role in blood pressure regulation [1, 2] . Recent experimental studies support the role of the a2B-adrenoceptor in the pathogenesis of hypertension. Indeed, ADRA2B knockout mice lack the immediate pressor response to a2-agonists [3] and fail to develop salt-induced hypertension, even after subtotal nephrectomy [4] . Inhibition of the central ADRA2B gene expression by antisense nucleotides can partly reverse the development of saltinduced hypertension [5, 6] .
The human a2B-adrenoceptor is encoded by the ADRA2B gene located on chromosome 2 [7] . The ADRA2B insertion/deletion (Insþ901Del [I/D]) polymorphism involves the deletion of three glutamic acids from a repeat element in the third intracellular loop of the protein [8, 9] . In vitro, the deletion has pronounced effects on the phosphorylation of the receptor and results in a loss of agonist-promoted desensitization [10] . Several reports in Caucasians revealed association of various cardiovascular and metabolic phenotypes with the ADRA2B I/D polymorphism [8, [11] [12] [13] [14] [15] . Middle-aged White men of the DD genotype have an increased risk of acute coronary events, fatal myocardial infarction and sudden cardiac death [16, 17] . To our knowledge, only one study investigated the ADRA2B I/D polymorphism in Asians. In Japanese, it was associated with increased sympathetic nervous activity, an intermediate phenotype possibly en route to the more distal cardiovascular and metabolic phenotypes [18] . The purpose of our study was to investigate whether the ADRA2B I/D polymorphism is associated with such phenotypes in a Chinese population.
Methods

Study population
We performed the present study in Taicang, a city 50 km west of Shanghai, China. According to the principles outlined in the Helsinki declaration for investigation of human participants, the Institutional Review Board of the Jiangsu Province Hospital, Nanjing Medical University approved the study protocol. All participants gave informed written consent. As previously reported [19] , we recruited nuclear families via specialized hypertension clinics, using hypertensive patients as index persons. Nuclear families consisted of either one parent and at least two offspring or two parents and one or more siblings. The study population included 493 participants. Nine participants had incomplete anthropometrical measurements and three participants could not be genotyped, leaving 481 participants for statistical analysis.
Measurement of phenotypes
We examined all participants at the outpatient clinic and visited them 1 or 2 weeks later at their homes. At the home visit, blood pressure was measured five times consecutively after 5 min rest in the sitting position. Hypertension was diagnosed if the average of the five blood pressure readings was at least 140 mmHg systolic or 90 mmHg diastolic or if the subjects were on antihypertensive medication. Weight and height were measured without shoes with the participants wearing light indoor clothing. Participants were classified as normal or overweight if their body mass index was less than 25 kg/m 2 or at least 25 kg/m 2 , respectively. The waist-to-hip ratio was the smallest circumference at the waist divided by the largest circumference at the hip. We used a standardized questionnaire to collect information on medical history, smoking habits, alcohol intake and use of medications.
Venous blood was sampled after overnight fasting. Routine biochemical measurements were performed in the central laboratory of the Jiangsu Province Hospital, Nanjing Medical University by an automated analyser (Chemistry Analyzer AU2700; Olympus Medical Engineering Company, Tokyo, Japan). Serum insulin was measured by radioimmunoassay (Multibulb Radiation Calculator DFM-96; Zhongcheng Technology Inc., Hefei, China). Diabetes was a fasting blood glucose concentration of at least 7.0 mmol/l or the use of antidiabetic medications. We also determined insulin resistance (homeostasis model assessment index) from fasting blood glucose and serum insulin [20] .
Determination of the genotype Genomic DNA was extracted from peripheral leukocytes by the proteinase K-phenol-chloroform method. The ADRA2B I/D polymorphism was determined, using the polymerase chain reaction conditions and primers as described by von Wowern et al. [14] .
Statistical methods
We used SAS version 8.1 (SAS Institute, Cary, North Carolina, USA) for database management and statistical analysis. Measurements with a skewed distribution were normalized by logarithmic transformation. We compared means and proportions by the standard normal z-test and the Fisher's exact test, respectively. We searched for possible correlates of the phenotypes under study by stepwise multiple regression with P values for covariates to enter and stay in the model set at 0.15.
To test for associations of continuous traits with the ADRA2B genotype, while adjusting for covariates as well as for clustering within families, we used generalized estimating equations (GEE). Our study sample included 106 families with two (n ¼ 73) or three (n ¼ 33) generations. Because there is no generally agreed algorithm to construct the variance-covariance matrix for correlated data within extended pedigrees, we pruned them into non-overlapping nuclear families, which yielded the maximum number of first-degree relatives. Moreover, to stabilize the working correlation matrix in the GEE approach, we removed 23 male and 29 female offspring whose birth order within a family was three or higher. Thus, the number of men and women analysed in the GEE analysis was 211 and 218, respectively. Retrospective power calculations were performed using the %POWER macro (http://ftp.sas.com/techsup/download/ stat/power.html). To test for associations of dichotomous traits with the ADRA2B genotype, we used logistic regression.
In the family-based analysis, we performed quantitative transmission disequilibrium tests (QTDT) with the same adjustment as in GEE. First, we evaluated the withinfamily and between-family components of phenotypic variance using the orthogonal model as implemented by Abecasis et al. [21] in the QTDT software (version 2.3 http://www.sph.umich.edu/csg/abecasis/QTDT). Second, using Waldman et al.'s approach [22] in the PROC LOGISTIC procedure of the SAS package, we modelled the probability of the transmission of the I allele from each heterozygous parent as a function of the quantitative phenotype.
Results
Characteristics of participants
The 234 male and 247 female participants had a mean age of 51.0 years. Table 1 provides further information on the characteristics of the participants by sex. The study sample included 215 (44.7%) hypertensive patients, of whom 178 took antihypertensive drugs. Antihypertensive treatment consisted of diuretics (n ¼ 104), b-blockers (n ¼ 56), calcium-channel blockers (n ¼ 109), angiotensin-converting enzyme inhibitors (n ¼ 62) or angiotensin II type-1 receptor blockers (n ¼ 2), given alone or in combination. None of the women took oral contraceptives or hormonal replacement therapy. Among men, 85 (36.3%) were current smokers and 101 (43.2%) reported intake of alcohol. In women, these numbers were two (0.8%) and six (2.4%), respectively. In smokers, the median number of cigarettes smoked per day was 10 (interquartile range, 7-20 cigarettes). Among drinkers, the median alcohol consumption was 8.0 g/day (interquartile range, 3.2-10.8 g/day).
Genotype and allele frequencies
The II (32.0%), ID (47.0%) and DD (21.0%) genotype frequencies were in Hardy-Weinberg equilibrium (P ¼ 0.29). The I-allele and D-allele frequencies were 55.5 and 45.5%, respectively. In men, but not in women, the frequencies of the I allele and the II genotype were ADRA2B gene and related phenotypes Zhang et al. 2203 significantly higher in hypertensive than normotensive subjects (P < 0.05; Table 2 ).
Association analysis
Covariates of the phenotypes under study, which were identified by stepwise regression, are presented in Table 3 . In logistic regression (Fig. 1) , while adjusting for covariates, II homozygous men had a 2.00 times (95% confidence interval, 1.22-3.27; P ¼ 0.006) higher risk of hypertension compared with the overall risk in all men; the relative risk compared with D-allele carriers was 2.61 (95% confidence interval, 1.28-5.32; P ¼ 0.008). Table 4 presents the adjusted phenotypes by ADRA2B genotype in men. Systolic blood pressure and body weight were significantly different between the three genotypes (P < 0.05) both before and after adjustment. With adjustments as presented in Table 3 (Table 5) .
Family-based QTDT analysis Our study sample included 106 families with two (n ¼ 73) or three (n ¼ 33) generations. We excluded five offspring because of errors in Mendelian inheritance. The orthogonal model did not reveal significant population stratification (0.11 < P < 0.93). The family-based analyses of 65 informative male offspring according to Abecasis' approach showed that transmission of the I allele was associated with higher systolic pressure (effect size 6.0 mmHg, P ¼ 0.10), diastolic pressure (5.5 mmHg, P ¼ 0.021) and faster pulse rate (5.8 beats/ min, P ¼ 0.019). Waldman's approach confirmed these findings. The x 2 values for systolic and diastolic blood pressures and pulse rate were 5.43 (P ¼ 0.020), 3.49 (P ¼ 0.062) and 3.96 (P ¼ 0.047), respectively.
Discussion
The key finding of our study was that systolic blood pressure increased and body weight decreased with the number of ADRA2B I alleles in men. Furthermore, compared with D-allele carriers, male II homozygotes had a lower body mass index and waist-to-hip ratio, lower serum insulin concentration and higher insulin sensitivity. The family-based analysis did not reveal significant population stratification and confirmed that, in male offspring, transmission of the I allele was associated with higher blood pressure.
Previous studies on the relation between blood pressure and the ADRA2B I/D polymorphism yielded inconsistent results. In two Scandinavian studies [13, 14] , the ADRA2B 
Alcohol intake Menopause
Smoking, alcohol intake, menopause and use of medications were coded 0 or 1 for condition absent or present, respectively.
Fig. 1
Relative risk of hypertension associated with the ADRA2B genotype in men. The risk of hypertension is expressed relative to that in all men and is adjusted for age, age 2 , body mass index, smoking and alcohol intake. Vertical lines denote 95% confidence intervals. For each genotype, the number of participants and hypertensive patients are presented.
DD genotype was associated with a higher risk of hypertension. However, Baldwin et al. [9] were unable to demonstrate linkage between hypertension and this polymorphism. Recently, Etzel et al. [23] sequenced 4.4 kb of the ADRA2B gene, including 1.2 kb upstream of and 1.9 kb distal to the coding sequence. They identified 25 polymorphisms, of which 14 were previously unreported, and two major haplotypes, which differed by the Insþ901Del (I/D) polymorphism. In keeping with the present findings, initial studies in 173 subjects revealed that carriers of one or two copies of haplotype 2, which included the insertion, had a higher mean arterial pressure at baseline and during infusion of yohimbine [23] . However, the same investigators could not replicate the significant association between blood pressure and the haplotype variation in the ADRA2B gene in sex-adjusted and age-adjusted analyses or in other larger cohorts [23] . They concluded that variation in ADRA2B might not be a major determinant of the susceptibility to hypertension [23] . However, the American group also demonstrated that the prevalence of the deletion polymorphism (42.9 versus 34.4%) and haplotype 6 (45.0 versus 29.2%), which encompassed the deletion, was substantially higher in Asians than Whites. Etzel et al. did not engage in ethnicity-specific analyses and they therefore did not exclude the possibility that the influence of the ADRA2B I/D polymorphism on the risk of hypertension might be greater in Asians than in Whites.
Our findings on body weight and serum insulin are in line with the results of three Finnish studies. Siitonen et al. [15] randomly assigned 506 subjects with impaired ADRA2B gene and related phenotypes Zhang et al. 2205 Values presented as arithmetic mean AE SE or geometric mean (95% confidence interval) adjusted for the covariates presented in Table 3 .
a Serum insulin and insulin resistance were available in 60 II, 96 ID and 39 DD participants, respectively. Values are presented as mean AE SE or geometric mean (95% confidence interval) adjusted for the covariates presented in Table 3 .
a Serum insulin and insulin resistance were available in 65 II, 97 ID and 48 DD participants, respectively. glucose tolerance to an intervention or control group, and found a significant interaction (P ¼ 0.003) between study group and the ADRA2B I/D polymorphism. In the control group, subjects carrying the D-allele had a higher risk of developing type 2 diabetes than II homozygotes. This increased risk was not observed in the intervention group, who showed significant weight loss. DD homozygotes also had the lowest acute insulin response to a glucose load (P ¼ 0.005). In a smaller study of non-diabetic obese subjects (n ¼ 166), the basal metabolic rate, determined by indirect calorimetry and adjusted for sex, age, fat mass and fat-free body mass, was 5.6% lower in DD homozygotes than in II homozygotes [8] . In a controlled 10-year follow-up study, Sivenius et al. [11] found in 126 non-diabetic control subjects, but not in 84 newly diagnosed type 2 diabetic patients, that the DD genotype was associated with an increased body weight.
To our knowledge, only one study has investigated the possible association of cardiovascular and metabolic phenotypes with the ADRA2B I/D polymorphism in Asians [18] . In 381 healthy male Japanese volunteers, the body mass index (21.6 AE 0.1 kg/m 2 ) and the plasma concentrations of glucose (5.2 AE 0.2 mmol/l) or insulin (47.8 AE 0.5 pmol/l) did not differ according to the ADRA2B genotypes [18] . However, in a subset of 93 subjects randomly selected for investigation of the autonomic nervous system, the authors also reported systolic and diastolic blood pressures across the ADRA2B I/D genotypes [18] . According to our calculations based on the reported Japanese results [18] , the pulse pressure was significantly higher in II homozygotes than D-allele carriers (50 versus 45 mmHg). The average body mass index in this Japanese study was similar to that in our study population, but it was substantially smaller than in the aforementioned Scandinavian studies (26.1-28.0 kg/m 2 ) [13, 14] . These findings in Japanese and Chinese populations therefore suggest that the ADRA2B I allele might be associated with higher blood pressure in lean subjects, the mechanisms for which are likely to be different from those underlying the increase in blood pressure in relation to overweight or the metabolic syndrome.
Retrospective power computations demonstrated that our study had 64% power to detect a significant association between systolic blood pressure and the ADRA2B I/D polymorphism. Our null findings in women might therefore be due to a lack of power. However, at least one other study [12] also reported gender-specific results. In Finnish non-diabetic men, but not women, DD homozygotes had a significantly lower autonomic tone in a cross-sectional analysis and a greater decline in parasympathetic tone compared with I-allele carriers in a 10-year longitudinal investigation [12] . Several experimental studies also lend support to gender differences in the regulation of the a2-adrenoceptor and its relation to blood pressure. Indeed, in normotensive and hypertensive rat models, male compared with female animals had a higher blood pressure and an elevated a2-adrenoceptor density in the kidneys [24, 25] . Castration of male spontaneously hypertensive rats reduced the malefemale differences in blood pressure and the renal a2-adrenoceptor density by 60% [24] . Overfeeding male rats raised the blood pressure and the density of renal a2-adrenoceptors, whereas such effect did not occur in female rats [26] . Although the precise mechanism underlying the male-female differences remains to be elucidated, sex hormones are probably involved. Indeed, testosterone stimulates the expression of a2B-adrenoceptors in spontaneously hypertensive rats [27] and is required for full expression of the receptor in salt-induced hypertension in male Sabra rats [28] .
The present study has to be interpreted within the context of its limitations. First, our study did not address the functionality of the ADRA2B I/D polymorphism. However, Small et al. [10] demonstrated that in transfected cells the deletion decreased agonist-promoted phosphorylation, which results in a complete loss of the ability of the receptor to undergo agonist-promoted desensitization. Second, our sample size was relatively small. We can therefore not exclude that the null findings in women might be due to a type II error. Third, we recruited families using hypertensive patients as index persons. Our results might therefore not be generalizable to the Chinese population at large. In addition, we did not adjust P values for multiple comparisons. However, if as in the present study phenotypes are correlated, then multiple testing is not indicated, because each new test does not provide a completely independent opportunity for a type I error [29] .
In conclusion, in Chinese men the I allele of the ADRA2B gene is associated with higher blood pressure, but probably also with a more favourable metabolic phenotype. If confirmed, our findings might have important clinical implications. Indeed, among 14 Chinese population samples, the prevalence of overweight and obesity was up to 48.1 and 9.5%, respectively [30] . The incidence of obesity is also rapidly increasing, especially in urban Chinese [31] . Along with hypertension and dyslipidaemia, obesity is one of the key features of the metabolic syndrome, which in prospective studies predicts the development of type 2 diabetes and cardiovascular disease [32] [33] [34] .
